carnitine has been researched along with Polyneuropathy, Acquired in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anikin, GS | 1 |
Makhova, AA | 1 |
Shikh, EV | 1 |
Olpin, SE | 1 |
Clark, S | 1 |
Andresen, BS | 1 |
Bischoff, C | 1 |
Olsen, RK | 1 |
Gregersen, N | 1 |
Chakrapani, A | 1 |
Downing, M | 1 |
Manning, NJ | 1 |
Sharrard, M | 1 |
Bonham, JR | 1 |
Muntoni, F | 1 |
Turnbull, DN | 1 |
Pourfarzam, M | 1 |
Roe, CR | 1 |
Roe, DS | 1 |
Wallace, M | 1 |
Garritson, B | 1 |
3 other studies available for carnitine and Polyneuropathy, Acquired
Article | Year |
---|---|
[Prospects of application of acetyl-L-carnitine in neurology and psychiatry (the treatment of polyneuropathy and depressive states)].
Topics: Acetylcarnitine; Carnitine; Depression; Humans; Neurology; Polyneuropathies; Psychiatry | 2019 |
Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Cardiomyopathies; Carnitine; Exons; Fatty Acids; Fibroblasts; Ho | 2005 |
Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Carnitine; Cell Line; Diet Therapy; Dietary Fats; Energy Intake; | 2007 |